Related Experiment Video
Updated: Jan 6, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
[Myelofibrosis: watch and wait or treat?]
1Universitätsklinik für Hämatologie, Onkologie, Hämostaseologie und Palliativmedizin, Johannes Wesling Klinikum Minden, Universitätsklinikum der Ruhr-Universität Bochum, Hans-Nolte-Straße 1, 32429, Minden, Deutschland. martin.griesshammer@muehlenkreiskliniken.de.
Myelofibrosis (MF) is a stem cell disease driven by JAK/STAT pathway activation, causing anemia and enlarged spleen. Treatment decisions for MF depend on risk, symptoms, and genetics, with JAK inhibitors and stem cell transplants offering therapeutic options.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
12:05Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Heart Failure V: Medical Management
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Myocarditis IV: Nursing Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management